Sphingomyelin levels in nondipper and dipper hypertensive patients

Zheng,Huan; Xie,Xiaoyun; Xie,Nanzi; Xu,Huifeng; Huang,Junling; Luo,Ming

doi:10.3892/etm.2013.1455

Sphingomyelin levels in nondipper and dipper hypertensive patients

Authors:
- Huan Zheng
- Xiaoyun Xie
- Nanzi Xie
- Huifeng Xu
- Junling Huang
- Ming Luo
View Affiliations

Affiliations: Geriatrics Department, Tongji Hospital Affiliated to Tongji University, Shanghai 20065, P.R. China, Cardiology Department, Tongji Hospital Affiliated to Tongji University, Shanghai 20065, P.R. China
Published online on: December 19, 2013 https://doi.org/10.3892/etm.2013.1455
Pages: 599-603

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A number of studies have focused on the association between sphingomyelin (SM) levels and atherosclerosis, however, there are few data concerning the correlation of SM with nondipper hypertension. The present study aimed to investigate the correlation between plasma SM levels and nondipper status in patients with hypertension. A total of 200 hypertensive patients were enrolled and divided into two groups according to their ambulatory blood pressure monitoring (AMBP) results: Dipper group (84 patients) and nondipper group (116 patients). All patients were subjected to transthoracic echocardiography examination and laboratory tests. No statistically significant difference was observed between the two groups in terms of basic clinical characteristics. However, the plasma SM levels in the dipper group were significantly lower than those of the nondipper group (41.9±17.5 vs. 96.4±14.3 mg/dl, P=0.003). The left ventricular mass index (LVMI) was higher in the nondipper patients than in the dipper patients and the diastolic function parameters in the nondipper patients were less favorable. Correlation analysis showed that the SM level was negatively correlated with the magnitude of systolic blood pressure (SBP) fall at night (r=-0.42, P<0.01) and diastolic blood pressure (DBP) fall at night (r=-0.31, P<0.01). The nondipper status had contributory effects on hypertensive concentric hypertrophy and diastolic function impairment. In addition, the plasma SM level was associated with a nondipper pattern of hypertension.

View Figures

View References

1	Izzedine H, Launay-Vacher V and Deray G: Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol. 107:343–349. 2006. View Article : Google Scholar : PubMed/NCBI
2	Della Mea P, Lupia M, Bandolin V, et al: Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am J Hypertens. 18:30–35. 2005.PubMed/NCBI
3	Kanbay M, Isik B, Akcay A, et al: Relation between serum calcium, phosphate, parathyroid hormone and ‘nondipper’ circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 27:516–521. 2007.
4	Ordu S, Ozhan H, Alemdar R, et al: Cystatin C levels in patients with dipper and nondipper hypertension. J Investig Med. 60:676–679. 2012.PubMed/NCBI
5	Brown DA and London E: Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem. 275:17221–17224. 2000. View Article : Google Scholar : PubMed/NCBI
6	Nelson JC, Jiang XC, Tabas I, Tall A and Shea S: Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol. 163:903–912. 2006. View Article : Google Scholar : PubMed/NCBI
7	Jiang XC, Paultre F, Pearson TA, et al: Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 20:2614–2618. 2000. View Article : Google Scholar : PubMed/NCBI
8	Kirkendall WM, Feinleib M, Freis ED and Mark AL: Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Circulation. 62:1146A–1155A. 1980.PubMed/NCBI
9	Mielke MM, Haughey NJ, Bandaru VV, et al: Plasma sphingomyelins are associated with cognitive progression in Alzheimer's Disease. J Alzheimers Dis. 27:259–269. 2011.PubMed/NCBI
10	Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 57:450–458. 1986. View Article : Google Scholar : PubMed/NCBI
11	Otterstad JE, Froeland G, St John Sutton M and Holme I: Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventriculardimensions and function. Eur Heart J. 18:507–513. 1997. View Article : Google Scholar : PubMed/NCBI
12	Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE and Shimada K: Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 38:852–857. 2001. View Article : Google Scholar : PubMed/NCBI
13	Oliveras A, Armario P, Martell-Clarós N, Ruilope LM and de la Sierra A; Spanish Society of Hypertension-Resistant Hypertension Registry. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives. Hypertension. 57:556–560. 2011. View Article : Google Scholar : PubMed/NCBI
14	Tigen K, Karaahmet T, Fotbolcu H, et al: The influence of dipper and nondipper blood pressure patterns on left ventricular functions in hypertensive patients: a tissue Doppler study. Turk Kardiyol Dern Ars. 37:101–106. 2009.PubMed/NCBI
15	Kumak F and Gungor H: Comparison of the left atrial appendage flow velocities between patients with dipper versus nondipper hypertension. Echocardiography. 29:391–396. 2012. View Article : Google Scholar : PubMed/NCBI
16	Rizzo V, Maio FD, Campbell SV, et al: Left ventricular function, cardiac dysrhythmias, atrial activation, and volumes in nondipper hypertensive individuals with left ventricular hypertrophy. Am Heart J. 139:529–536. 2000.PubMed/NCBI
17	Mann S, Altman DG, Raftery EB and Bannister R: Circadian variation of blood pressure in autonomic failure. Circulation. 68:477–483. 1983. View Article : Google Scholar : PubMed/NCBI
18	Sherwood A, Routledge FS, Wohlgemuth WK, Hinderliter AL, Kuhn CM and Blumenthal JA: Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens. 24:982–988. 2011. View Article : Google Scholar : PubMed/NCBI
19	Kaya MG, Yarlioglues M, Gunebakmaz O, et al: Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis. 209:278–282. 2010. View Article : Google Scholar : PubMed/NCBI
20	Ermis N, Yagmur J, Acikgoz N, et al: Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens. 34:311–315. 2012. View Article : Google Scholar : PubMed/NCBI
21	Maio R, Perticone M, Sciacqua A, et al: Oxidative stress impairs endothelial function in nondipper hypertensive patients. Cardiovasc Ther. 30:85–92. 2012. View Article : Google Scholar : PubMed/NCBI
22	Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T and Yoshimatsu H: Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res. 26:669–676. 2003. View Article : Google Scholar : PubMed/NCBI
23	Demir M, Günay T, Özmen G and Melek M: Relationship between vitamin D deficiency and nondipper hypertension. Clin Exp Hypertens. 35:45–49. 2013. View Article : Google Scholar : PubMed/NCBI
24	Hla T and Dannenberg AJ: Sphingolipid signaling in metabolic disorders. Cell Metab. 16:420–434. 2012. View Article : Google Scholar
25	Jiang XC, Goldberg IJ and Park TS: Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. Adv Exp Med Biol. 721:19–39. 2011. View Article : Google Scholar : PubMed/NCBI